President Joe Biden will formally announce his 2024 reelection campaign as soon as next week, three people briefed on the discussions said Thursday.

The people, who spoke on the condition of anonymity to discuss internal deliberations, said they were not aware that a final decision on timing had been made, but that Biden had been eyeing Tuesday, April 25, four years to the day since the Democrat entered the 2020 race. The upcoming announcement is expected to be in the form of a video released to supporters.

Biden, 80, has repeatedly said he intends to run for a second term but advisers say he has felt little need to jump into campaigning because he faces no significant opposition to his party's nomination.

It'll be a markedly different experience from four years ago, as when Biden was written off by much of the political establishment until he consolidated support as the candidate Democrats believed was best positioned to defeat then-President Donald Trump while the coronavirus pandemic raged. This time around, he will have to juggle the challenge of running for reelection while also running the country.

Biden in recent months has been focused on implementing the massive infrastructure, technology investment and climate laws passed during his first two years in office and drawing a sharp contrast with Republicans as Washington gears up for a fight over raising the nation’s borrowing limit. Aides believe those priorities will burnish his image ahead of his reelection campaign.

The president, already the oldest person ever elected the job, will also need to contend with voter concerns about his fitness for the job. He has brushed aside those concerns, telling voters to “watch me,” and aides say he plans to mount a robust campaign ahead of what they expect to be a close general election owing to the country's polarization, no matter who emerges as the GOP standard-bearer.

Biden has summoned top Democratic donors to Washington next week for what was expected to be a dinner with him and a strategy session with his chief political advisers.

The Washington Post first reported on the expected timing of the announcement.

Share:
More In Politics
Trump suggests canceling Xi meeting and threatens more tariffs after China restricts key exports
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More